Zenas Bio: Recent IPO With Late-Stage Candidate
Zenas BioPharma's obexelimab demonstrates strong clinical results, but financial uncertainties remain. See more on ZBIO stock and the current market outlook.
kalkinemedia17h
TreeHouse Foods Faces Expanded Safety Concerns
Highlights,TreeHouse Foods expands recall for frozen waffle and pancake products.,Contamination concerns involve Listeria ...
More than HALF of prisoners released in the first three months of this year are already back in prison as probation chief warns Labour's prison overcrowding plans …
Martin Jones, His Majesty's Chief of Probation, told how for every 100 inmates released, 56 were recalled for reoffending or ...
Pfizer has “significantly overpaid” for recent acquisitions: Starboard Value
Pfizer (PFE) faces renewed calls for change as Jeffrey Smith, CEO of Starboard Value makes his case for his activist stance ...